The EU Commission clears, subject to divestiture, an acquisition in the healthcare sector (Johnson and Johnson / Pfizer)

"Mergers — Main developments between 1 September and 31 December 2006"* On 11 December the Commission cleared Johnson & Johnson’s (“J&J”) proposed acquisition of Pfizer’s consumer healthcare business (“PCH”) subject to conditions. J&J is a leading healthcare group active worldwide in three business segments: pharmaceuticals, consumer products and medical devices and diagnostics. PCH is Pfizer’s worldwide business division active in over-the-counter (“OTC”) pharmaceuticals and personal care products. The Commission’s investigation

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • JG Associates (Brussels)
  • DG COMP (Brussels)

Quotation

John Gatti, Mary Loughran, The EU Commission clears, subject to divestiture, an acquisition in the healthcare sector (Johnson and Johnson / Pfizer), 11 December 2006, e-Competitions Bulletin December 2006, Art. N° 38254

Visites 215

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues